In order to block the use of electronic surgical tools used to remove fibroids, which can also inadvertently spread cancer throughout the body, American citizens including cancer patients, their family members and physicians called on U.S. health regulators on Friday.
Mostly among women in their late 30s and 40s, Fibroids are non-cancerous growths in the uterus that can cause severe pain, heavy bleeding, and bladder and bowel dysfunction. The cause of the tumor-like growths is not clear but they account for an estimated 240,000 of the 600,000 annual hysterectomies in the U.S.
According to FDA health advisers, a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body and There no evidence regarding this.
U.S. health advisers said on Friday that surgical technique used to grind up uterine growths and remove them through tiny incisions won’t increase the risk of spreading cancer to other parts of a woman’s body cannot be guaranteed.
Unaware of the cancer risks of the popular technique for treating fibroids, women with cancer and family members of deceased patients plead in front of an expert panel of Food and Drug Administration advisers.
A written consent stating that they understand the potential risks should be signed by the women who undergo the procedure called laparoscopic power morcellation, said the advisory panel of the Food and Drug Administration.
Though the agency usually follows the advice or recommendations of its advisory committees but it isn’t obliged to do so. The FDA hasn’t set a decision date on the use of power morcellator devices.
While performing a hysterectomy or removing uterine fibroids, which are noncancerous growths on the smooth muscle tissue on the wall of the uterus, laparoscopic power morcellation is frequently used by the Surgeons.
At least 50,000 U.S. women undergo hysterectomy using the power morcellation technique.
A non-power version of the morcellator received FDA approval in 1991 and it approved the first power morcellator for use in 1995.
The medical community has been aware of the risk of cancer spread during power morcellation since the devices came onto the market, but the magnitude of the risk appears to be higher than what was appreciated in the clinical community.
Latest posts by Kevin Calderon (see all)
- AMD Epyc Processor Units – A Rival for Intel? - Jun 22, 2017
- Climate Change Study Had To Be Postponed Due To The Severe Ice Conditions - Jun 15, 2017
- Aldi Is Planning On Increasing Its Presence In The US Market - Jun 12, 2017